Counterpart Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Counterpart Ventures/Activity

Counterpart Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

4 investments· FEB 2026 – AUG 2026Show all

Investment

Counterpart Ventures participated in Arintra's $25M Series B round alongside Define Ventures (lead), Peak XV Partners, Spider Capital, Endeavor Health Ventures, and others. Arintra is an AI-driven revenue assurance platform for healthcare.

Arintra

Arintra Counterpart Ventures

counterpart.vcAUG 26, 2026

AUG 26, 2026

Investment

Counterpart Ventures participated in GrailPay's $10.5M Series A round (MissionOG led) to build the trust layer for instant B2B payments. GrailPay provides real-time risk detection for bank payments on RTP and FedNow rails.

Grailpay

Grailpay Counterpart Ventures

counterpart.vcJUN 25, 2026

JUN 25, 2026

Investment

Announced an investment in Zelody's pre-seed round for financial data orchestration.

Zelody

Zelody Counterpart Ventures

counterpart.vcFEB 12, 2026

FEB 12, 2026

Investment

Participated as an existing investor in Oxide Computer Company's $200M Series C.

Oxide Computer

Oxide Computer Counterpart Ventures

counterpart.vcFEB 10, 2026

FEB 10, 2026

Exit

Portfolio company Particle was acquired by Digi International for $50M.

Particle

Particle Counterpart Ventures

particle.ioJAN 27, 2026

JAN 27, 2026

Investment

Participated in Oxide's $200M Series C follow-on investment, 9 months after their Series B.

Oxide Computer

Oxide Computer Counterpart Ventures

counterpart.vcDEC 23, 2025

DEC 23, 2025

Essay

Tanvi Narain published a thought leadership essay on enterprise adoption of AI agents, featuring insights from a fireside chat with Cisco and Snorkel AI leaders on how enterprises evaluate, discover, and implement agentic AI solutions.

Counterpart Ventures

Counterpart VenturesCounterpart Ventures

counterpart.vcNOV 3, 2025

NOV 3, 2025

Exit

Glidian, a Counterpart Ventures portfolio company and prior authorization automation leader, was acquired by Infinx to expand patient access solutions and revenue cycle management capabilities.

Glidian

Glidian Counterpart Ventures

prnewswire.comMAR 25, 2025

MAR 25, 2025